Literature DB >> 2199282

Going both ways: bispecific antibodies and targeted cellular cytotoxicity.

M W Fanger, D M Segal, J R Wunderlich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2199282     DOI： 10.1096/fasebj.4.11.2199282

Source DB:  PubMed          Journal:  FASEB J        ISSN： 0892-6638            Impact factor:   5.191


× No keyword cloud information.
  3 in total

Review 1.  Symmetry breaking: bispecific antibodies, the beginnings, and 50 years on.

Authors:  Gert Riethmüller
Journal:  Cancer Immun       Date:  2012-05-01

2.  The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK cells and induces direct phagocytosis of tumour cells.

Authors:  R Zeidler; J Mysliwietz; M Csánady; A Walz; I Ziegler; B Schmitt; B Wollenberg; H Lindhofer
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

3.  Generation of chimeric bispecific G250/anti-CD3 monoclonal antibody, a tool to combat renal cell carcinoma.

Authors:  R M Luiten; L R Coney; G J Fleuren; S O Warnaar; S V Litvinov
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.